Raman‐controlled pyruvate feeding to control metabolic activity and product quality in continuous biomanufacturing
Biotechnology Journal · 2024-01 · 19 (1)
DOI: 10.1002/biot.202300318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 07.11.2023. Verfasst von Patrick Romann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Pharma Technology, School of Life Science, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland. Hauptthemen laut MEDLINE: Pyruvic Acid, Antibodies, Monoclonal. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Merck Serono SA (an affiliate of Merck KGaA, Darmstadt, Germany).
Abstract (Originalsprache)
Background Despite technological advances ensuring stable cell culture perfusion operation over prolonged time, reaching a cellular steady‐state metabolism remains a challenge for certain manufacturing cell lines. This study investigated the stabilization of a steady‐state perfusion process producing a bispecific antibody with drifting product quality attributes, caused by shifting metabolic activity in the cell culture. Main methods A novel on‐demand pyruvate feeding strategy was developed, leveraging lactate as an indicator for tricarboxylic acid (TCA) cycle saturation. Real‐time lactate monitoring was achieved through in‐line Raman spectroscopy, enabling accurate control at predefined target setpoints. Major results The implemented feedback control strategy resulted in a three‐fold reduction of ammonium accumulation and stabilized product quality profiles. Stable and flat glycosylation profiles were achieved with standard deviations below 0.2% for high mannose and fucosylation. Whereas galactosylation and sialylation were stabilized in a similar manner, varying lactate setpoints might allow for fine‐tuning of these glycan forms. Implication The Raman‐controlled pyruvate feeding strategy represents a valuable tool for continuous manufacturing, stabilizing metabolic activity, and preventing product quality drifting in perfusion cell cultures. Additionally, this approach effectively reduced high mannose, helping to mitigate increases associated with process intensification, such as extended culture durations or elevated culture densities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Pharma Technology, School of Life Science, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland.
- Research Division Biochemical Engineering, Institute of Chemical Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria.
- Biotech Process Science, Merck Serono SA (an affiliate of Merck KGaA, Darmstadt, Germany), Corsier-sur-Vevey, Switzerland.
ORCID-Profile: Patrick Romann, Christoph Herwig, Thomas K Villiger
Förderung
- Merck Serono SA (an affiliate of Merck KGaA, Darmstadt, Germany)
Zitieren
APA
Romann, P., Schneider, S., Tobler, D., Jordan, M., Perilleux, A., Souquet, J., Herwig, C., Bielser, J. M., & Villiger, T. K. (2024). Raman‐controlled pyruvate feeding to control metabolic activity and product quality in continuous biomanufacturing. Biotechnology Journal, 19(1). https://doi.org/10.1002/biot.202300318
Vancouver
Romann P, Schneider S, Tobler D, Jordan M, Perilleux A, Souquet J, et al. Raman‐controlled pyruvate feeding to control metabolic activity and product quality in continuous biomanufacturing. Biotechnology Journal. 2024;19(1). doi:10.1002/biot.202300318
BibTeX
@article{Romann2024,
author = {Romann, Patrick and Schneider, Sebastian and Tobler, Daniela and Jordan, Martin and Perilleux, Arnaud and Souquet, Jonathan and Herwig, Christoph and Bielser, Jean-Marc and Villiger, Thomas K},
title = {Raman‐controlled pyruvate feeding to control metabolic activity and product quality in continuous biomanufacturing},
journal = {Biotechnology Journal},
year = {2024},
volume = {19},
number = {1},
doi = {10.1002/biot.202300318}
}
EUVIMED